Hint mode is switched on Switch off
For swift navigation between sections

TC Biopharm (Holdings)
LEI 5493006WD64125Z37884

PDF download

Choose all Reset all
Download Cancel
Organization name
TC Biopharm (Holdings) plc
Country name
United Kingdom
Country of registration
United Kingdom
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.

Awards

News

24/05/2024 TC Biopharm (Holdings): Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
06/05/2024 TC Biopharm (Holdings): Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Other Events, Financial Statements And Exhibits
01/05/2024 TC Biopharm (Holdings): Other Events, Financial Statements And Exhibits
01/04/2024 TC Biopharm (Holdings): Other Events, Financial Statements And Exhibits
14/03/2024 TC Biopharm (Holdings): Submission Of Matters To A Vote Of Shareholders
All organization news

Documentation

IFRS/US GAAP reports

2024
I q eng
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493006WD64125Z37884
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001872812
Registration is required to get access.